心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06609 心玮医疗-B

休市中 07-03 15:58:24

44.620

+1.300

+3.00%

最高45.000	最低43.300	成交量3.17万
今开43.300	昨收43.320	日振幅3.92%
总市值17.34亿	流通市值13.65亿	总股本3,886万
成交额140.33万	换手率0.10%	流通股本3,059万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06609","market":"HK","secType":"STK","nameCN":"心玮医疗-B","latestPrice":44.62,"timestamp":1783065504886,"preClose":43.32,"halted":0,"volume":31700,"delay":0,"changeRate":0.03000923361034158,"floatShares":30593400,"shares":38862000,"eps":2.543242586100065,"marketStatus":"休市中","change":1.3,"latestTime":"07-03 15:58:24","open":43.3,"high":45,"low":43.3,"amount":1403342,"amplitude":0.039243,"askPrice":45.98,"askSize":300,"bidPrice":44.6,"bidSize":500,"shortable":0,"etf":0,"ttmEps":2.543242586100065,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":7,"adr":0,"listingDate":1629388800000,"exchange":"SEHK","adjPreClose":43.32,"openAndCloseTimeList":[[1783042200000,1783051200000],[1783054800000,1783065600000]],"volumeRatio":0.879334,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06609/wiki","defaultTab":"wiki","newsList":[{"id":"1118341198","title":"心玮医疗-B批准H股回购计划，最高斥资1亿港元回购最多100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1118341198","media":"投资观察","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118341198?lang=zh_cn&edition=full","pubTime":"2026-07-03 19:13","pubTimestamp":1783077225,"startTime":"0","endTime":"0","summary":"上海心玮医疗科技股份有限公司（06609.HK）于6月29日宣布，其董事会已批准一项H股回购计划。根据该计划，公司拟动用不超过1亿港元的资金，在公开市场上回购不超过100万股H股。\n此项回购计划旨在优化公司资本结构，提升每股收益，并彰显管理层对公司未来长期发展前景的信心。市场分析认为，此举有助于向投资者传递积极信号，并可能对股价形成支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609","BK1574","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158953629","title":"心玮医疗-B发布2026年6月股份变动月报表，非上市股增至8,268,604股","url":"https://stock-news.laohu8.com/highlight/detail?id=1158953629","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158953629?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:15","pubTimestamp":1782983754,"startTime":"0","endTime":"0","summary":"2026年7月2日，上海心瑋醫療科技股份有限公司披露了截至2026年6月30日的股份变动月报表。公告显示，公司注册股本由上月末的人民币31,565,804元（H股）及人民币7,268,604元合计人民币38,834,408元，增加至报告期末的人民币39,834,408元。与此同时，公司的非上市股（普通股）由上月底的7,268,604股增加至8,268,604股，新增1,000,000股内资股，认购价格为每股45港元。上述新增股份已获得公司股东大会及类别股东大会批准。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198145995","title":"心玮医疗-B发行100万股非上市股份，涉资约4,500.00万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198145995","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198145995?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:26","pubTimestamp":1782743174,"startTime":"0","endTime":"0","summary":"心玮医疗-B (06609)于2026年6月29日发布公告，董事会批准发行1,000,000股非上市股份，每股认购价格45港元，涉资约4,500.00万港元。根据公告，本次发行股份数量占原有7,268,604股非上市股份的约13.76%。\n发行完成后，公司非上市股份由7,268,604股增至8,268,604股；H股方面与公司库藏股数保持不变，分别为30,593,404股与972,400股，合计31,565,804股。公司公告同时确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。\n本次公告由董事王国辉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"心玮医疗-B发行100万股非上市股份，涉资约4,500.00万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647337774","title":"心玮医疗-B(06609.HK)拟回购不超过1亿港元的H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647337774","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647337774?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:16","pubTimestamp":1782742572,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","06609","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647377708","title":"心玮医疗-B(06609.HK)完成发行100万股内资股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647377708","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647377708?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:15","pubTimestamp":1782742528,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","06609","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168962977","title":"心玮医疗-B批准H股回购计划 斥资最高1亿港元购回最多100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1168962977","media":"美股速递","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168962977?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:15","pubTimestamp":1782742518,"startTime":"0","endTime":"0","summary":"上海心玮医疗科技股份有限公司（心玮医疗-B）董事会已批准一项H股回购计划。根据该计划，公司获授权动用不超过1亿港元资金，在公开市场购回最多100万股H股。\n此项回购计划旨在优化公司资本结构，提升每股收益，并彰显管理层对公司未来发展的信心。回购行动将在符合香港联合交易所有限公司证券上市规则及相关法律法规的前提下进行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609","BK1100","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642281428","title":"心玮医疗-B(06609)：丁魁辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2642281428","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642281428?lang=zh_cn&edition=full","pubTime":"2026-06-10 19:09","pubTimestamp":1781089786,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，丁魁先生因其他个人事务已辞任非执行董事、董事会审计委员会及董事会战略委员会成员职务，自2026年6月10日起生效。独立非执行董事郭少牧先生于丁先生辞任后已获委任为审计委员会成员。其任期将于当前第二届董事会任期届满为止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","06609","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162599471","title":"心玮医疗-B2026年5月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1162599471","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162599471?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:43","pubTimestamp":1780476194,"startTime":"0","endTime":"0","summary":"上海心瑋醫療科技股份有限公司于2026年6月3日发布2026年5月股份变动月报表。公告显示，截至2026年5月31日，公司已发行普通股合计共38,834,408股，包括H股31,565,804股及非上市股7,268,604股，注册股本与上月持平。截至5月底，心玮医疗-B已符合香港联交所相关公众持股量要求。公告由公司董事王国辉于2026年6月3日签署，公司确认将继续遵守香港联交所《上市规则》及相关法律法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640827269","title":"脑机接口概念股走高 蓝思科技(06613)涨7.48% 机构指5月商保覆盖标志行业向普惠化、商业化迈进","url":"https://stock-news.laohu8.com/highlight/detail?id=2640827269","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640827269?lang=zh_cn&edition=full","pubTime":"2026-06-01 10:15","pubTimestamp":1780280113,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股脑机接口概念股全线走高，截至发稿，联想集团 涨10.08%，蓝思科技涨7.48%，心玮医疗-B涨3.52%，南京熊猫电子股份涨2.02%，微创脑科学涨1.41%。该机构认为：从2025年3月医保局为脑机接口收费立项到2026年5月商保覆盖，脑机接口支付端已经实现从手术费到耗材支出全链路打通，脑机接口真正向普惠化、商业化迈进。基于此，该机构认为，随着商业保险覆盖，行业正实现商业闭环，投融资底层逻辑已从前瞻性技术布局转向高确定性的产业投资。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982615","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0264606111.USD","02172","LU0310800965.SGD","LU1235295612.USD","BK1526","LU0052756011.USD","BK0201","LU0572939691.SGD","80992","LU0791590937.USD","06609","LU2242644610.SGD","BK1193","00553","HK0000306685.HKD","BK1100","HK0000320223.HKD","300433","BK0076","LU1046422090.SGD","HK0000320264.USD","LU1366334578.USD","BK1149","BK1170","IE0034224299.USD","HK0000306701.USD","BK1574","BK1587","IE0032431581.USD","LNVGY","LU0049112450.USD","LU1934453819.USD","BK1607","06613","BK0028","BK0196","SGXZ49509284.SGD","00992","LU0791591158.USD","BK0214","LU1267930227.SGD","BK0072","LU0128525689.USD","LU0572940350.SGD","BK0064","LU1366334651.USD","LU1979443071.USD","IE00B0JY6N72.USD","SGXZ81163826.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637387783","title":"心玮医疗-B(06609)根据特别授权认购新内资股获中国证监会同意注册的批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2637387783","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637387783?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:54","pubTimestamp":1779360890,"startTime":"0","endTime":"0","summary":"四、 自中国证监会同意注册之日起至本次发行结束前，本公司如发生重大事项，应及时报告中国证监会并按有关规定处理。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B(06609)根据特别授权认购新内资股获中国证监会同意注册的批复","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06609","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636002633","title":"港股概念追踪 | 国内首次！128通道全植入式脑机接口开启临床试验，脑机接口产业落地有望提速(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636002633","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636002633?lang=zh_cn&edition=full","pubTime":"2026-05-19 07:46","pubTimestamp":1779147991,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，5月18日，我国正式启动首个128通道全植入式脑机接口系统多中心临床试验，这项试验由首都医科大学附属北京天坛医院担任组长单位，标志着我国自主研发的全侵入式脑机接口技术加速进入临床转化阶段。据悉，此次研究采用的侵入式脑机接口系统，由皮层内植入式柔性电极与高集成度全植入式信号采集器两大模块构成。团队将完成128通道系统的安全性和有效性验证。本次临床试验将为更高阶的脑机接口技术积累关键数据。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/f98cd56d60416e16704eeca3f233a320","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/f98cd56d60416e16704eeca3f233a320"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443199.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1149","BK1170","VXUS","BK1587","00553","06613","BK4585","BK4588","06609","BK1100","02172","BK1574"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2635943788","title":"格隆汇个股放量排行榜 | 5月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635943788","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635943788?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:30","pubTimestamp":1778664605,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日腾讯音乐-SW(01698)、阳光保险(06963)、上海电气(02727)、轻松健康(02661)、弘毅文化集团(00419)、FIT HON TENG(06088)、京城机电股份(00187)、北方矿业(00433)、心玮医疗-B(06609)、同源康医药-B(02410)、富通科技(00465)、京东物流(02618)、云顶新耀(01952)、赛晶科技(005","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/13173057083788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["03888","06996","09858","03700","00772","02172","02256","01024","01783","01833","02126","09699","06660","02276","09626","02306","09688","81024","06609","01357","02618","01060","06969","06049","02252","01905","02158","09888","02013","01952","02285","06160","00719","02197","02192","00762","00136","02096","01440","00013","01951","02171","06060","09992","06963","00169","01548","06186","03692","00909"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102538891","title":"心玮医疗-B4月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1102538891","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102538891?lang=zh_cn&edition=full","pubTime":"2026-05-06 12:17","pubTimestamp":1778041055,"startTime":"0","endTime":"0","summary":"上海心瑋醫療科技股份有限公司于2026年5月6日发布截至2026年4月30日的股份变动月报。根据公告内容，本期公司已发行及注册股本无新增发行或回购活动，各类股份数量保持不变。公司本月底法定/注册股本总额为人民币38,834,408元，与上月底保持一致。报告显示，月内未有新增发行、购回或注销股份，也不存在任何涉及发行人股份的期权、权证、可换股票据或其他安排的变动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103099347","title":"心玮医疗-B授予股份购回授权，规模最高可达已发行H股一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1103099347","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103099347?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:45","pubTimestamp":1777286750,"startTime":"0","endTime":"0","summary":"心玮医疗-B在最新公布的股东周年大会通告中提出一项股份购回授权议案。根据议案内容，如获股东大会批准，公司将被授权于股东大会通过决议之日起至下届股东周年大会结束前，回购不超过当日已发行H股股份总数约10%的股份。据公告，股东周年大会暂定于2026年5月28日举行。届时，公司也将就其他相关议案进行审议。凡在指定日期登记在册并符合条件的股东，均可出席并对购回议案进行表决。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"心玮医疗-B授予股份购回授权，规模最高可达已发行H股一成","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173249799","title":"心玮医疗-B2025年收入大增46.9%至约4.08亿元 扭亏录得净利约0.83亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173249799","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173249799?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:30","pubTimestamp":1777285853,"startTime":"0","endTime":"0","summary":"心玮医疗-B在2025年度实现营业收入约人民币4.08亿元，同比上升46.9%，并由上年亏损转为盈利，录得净利润约人民币0.83亿元。公司管理层指出，收益增长主要受到神经介入领域相关创新器械的销售规模提升以及海外市场拓展的带动，出血性卒中板块收入同比增长223.2%，海外市场增幅达101.3%。截至2025年末，公司资产约为人民币12.92亿元，负债总额约为1.60亿元，股东权益由上年度约10.62亿元上升至11.32亿元，现金及现金等价物结余为4.56亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"心玮医疗-B2025年收入大增46.9%至约4.08亿元 扭亏录得净利约0.83亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629709870","title":"脑机接口概念板块逆市有支撑 机构指中国脑机接口产业进入高速发展轨道","url":"https://stock-news.laohu8.com/highlight/detail?id=2629709870","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629709870?lang=zh_cn&edition=full","pubTime":"2026-04-22 10:38","pubTimestamp":1776825522,"startTime":"0","endTime":"0","summary":"金吾财讯 | 脑机接口概念板块逆市有支撑，截止发稿，南京熊猫电子股份 涨1.83%，心玮医疗-B涨1.12%，蓝思科技涨0.78%。建银国际证券指，脑机接口正加速从实验室研究迈向商业应用。中国脑机接口产业已进入高速发展轨道，并在特定细分领域展现出全球竞争力。全球脑机接口市场规模2025年已达约26亿美元，潜力巨大。脑机接口现正从科幻概念演变为实用医疗乃至未来的医疗主导的跨行业消费平台。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979632","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00553","BK1587","BK1170","06609","06613","BK1149","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169539800","title":"心玮医疗-B更新3月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1169539800","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169539800?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:46","pubTimestamp":1775115988,"startTime":"0","endTime":"0","summary":"心玮医疗-B（股票代码：06609）于2026年4月2日披露的截至2026年3月31日的股份变动月报表显示，公司本月无新增发行、购回或注销活动，股本结构维持稳定。\n根据公告，截至2026年3月31日，公司注册股本总额为人民币38,834,408元，包含31,565,804股已在香港联交所上市的H股，以及7,268,604股非上市股份。两类股份本月均未发生变动。H股在本月末的已发行股份数量为30,593,404股，另有972,400股作为库存股份持有。\n公告信息显示，该公司确认符合香港联交所《上市规则》的最低公众持股量要求。本次月报由公司董事王国辉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597075","title":"首次实现年度高质量盈利，心玮医疗-B(06609)迎业绩拐点与估值修复双重逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597075","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624597075?lang=zh_cn&edition=full","pubTime":"2026-04-01 19:06","pubTimestamp":1775041600,"startTime":"0","endTime":"0","summary":"近日，心玮医疗-B2025年年度业绩正式出炉。报告期内，该产品已进入超过450家医院，头部医院渗透率达26%，带动销量增长约300%。除了现金牛业务的稳健表现外，心玮医疗2025年的出血业务“显著增量”也是财报中的一大亮点。而期内血流导向装置的获批上市，则进一步补齐心玮出血业务的重要拼图。与此同时，期内首次实现年度盈利，也预示着心玮医疗已稳步进入“创新-盈利”正循环。目前心玮医疗的海外业务还在有序开展，产品注册稳步推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"首次实现年度高质量盈利，心玮医疗-B(06609)迎业绩拐点与估值修复双重逻辑","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06609","BK1587","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147314330","title":"异动解读 | 业绩扭亏为盈且增长强劲，心玮医疗-B盘中大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147314330","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147314330?lang=zh_cn&edition=full","pubTime":"2026-03-30 13:29","pubTimestamp":1774848546,"startTime":"0","endTime":"0","summary":"心玮医疗-B今日盘中股价大幅上涨5.35%，引起了市场的广泛关注。消息面上，公司此前发布的2025年年度业绩显示其成功实现重大扭亏为盈。报告期内，公司实现营业收入4.08亿元，同比增长46.9%；净利润达到8334万元，相较2024年的亏损1362万元，业绩表现显著改善。公司的增长动力来自缺血性、出血性卒中及介入通路三大业务板块的梯次发力，其中出血性卒中业务收入同比暴增223.2%。海外市场拓展迅速，收入同比增长101.3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622856847","title":"业绩会直击|心玮医疗-B（6609.HK）：2025迈入规模化盈利，全球化与研发管线双维突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2622856847","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622856847?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:50","pubTimestamp":1774605002,"startTime":"0","endTime":"0","summary":"2025年公司实现营收4.08亿元，同比增长46.9%，过去五年营收CAGR达46%；归母净利润为8334万元，成功扭亏为盈，相较上年度净亏损约1362万元改善幅度超710%。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4218654","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1100","06609","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.strokemedical.com","stockEarnings":[{"period":"1week","weight":0.1006},{"period":"1month","weight":-0.0445},{"period":"3month","weight":-0.0735},{"period":"6month","weight":-0.1828},{"period":"1year","weight":0.2326},{"period":"ytd","weight":-0.1691}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海心玮医疗科技股份有限公司是一家主要从事医疗器械研发、生产和商业化的中国公司。该公司的主要神经介入产品及在研产品包括缺血性脑卒中取栓器械，如Captor取栓器械和颅内血栓抽吸导管，颅内动脉狭窄治疗器械，如颅内球囊扩张导管及颈动脉球囊扩张导管和栓塞保护系统，出血性脑卒中治疗器械，如颅内动脉瘤栓塞辅助支架和血流导向装置，缺血性脑卒中预防器械，如左心耳封堵器，以及血管通路器械如远端通路导管、微导管、封堵球囊导管等。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.1064},{"month":2,"riseRate":0.4,"avgChangeRate":-0.067342},{"month":3,"riseRate":0.4,"avgChangeRate":-0.0145},{"month":4,"riseRate":0.4,"avgChangeRate":-0.01346},{"month":5,"riseRate":0.2,"avgChangeRate":-0.061255},{"month":6,"riseRate":0.4,"avgChangeRate":0.043804},{"month":7,"riseRate":0.6,"avgChangeRate":0.072409},{"month":8,"riseRate":0.5,"avgChangeRate":-0.063767},{"month":9,"riseRate":0.6,"avgChangeRate":0.057771},{"month":10,"riseRate":0.4,"avgChangeRate":-0.058186},{"month":11,"riseRate":0.4,"avgChangeRate":0.057501},{"month":12,"riseRate":0.8,"avgChangeRate":0.076512}],"exchange":"SEHK","name":"心玮医疗-B","nameEN":"HEARTCARE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心玮医疗-B,06609,心玮医疗-B股票,心玮医疗-B股票老虎,心玮医疗-B股票老虎国际,心玮医疗-B行情,心玮医疗-B股票行情,心玮医疗-B股价,心玮医疗-B股市,心玮医疗-B股票价格,心玮医疗-B股票交易,心玮医疗-B股票购买,心玮医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}